Efficacy and Safety of Gecacitinib Hydrochloride in Prophylaxis Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelofibrosis
Clinical trial NCT07440654 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07440654
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2029-09-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.